找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Diagnostic and Therapeutic Antibodies; Andrew J. T. George,Catherine E. Urch Book 2000 Humana Press 2000

[復制鏈接]
查看: 29741|回復: 60
樓主
發(fā)表于 2025-3-21 17:37:42 | 只看該作者 |倒序瀏覽 |閱讀模式
書目名稱Diagnostic and Therapeutic Antibodies
編輯Andrew J. T. George,Catherine E. Urch
視頻videohttp://file.papertrans.cn/271/270738/270738.mp4
概述Includes supplementary material:
叢書名稱Methods in Molecular Medicine
圖書封面Titlebook: Diagnostic and Therapeutic Antibodies;  Andrew J. T. George,Catherine E. Urch Book 2000 Humana Press 2000
描述Soon after the first description of monoclonal antibodies in 1976, there was enormous interest in the clinical application of antibodies, especially in the context of cancer. Antibodies appeared to offer the “magic bullet” that would allow the specific destruction of neoplastic cells. H- ever, many years’ effort resulted in very few cases of successful immu- therapy with antibodies. As a result there was a major backlash against antibody therapy, and the field lost a considerable amount of popularity. Fashion, in science as well as in other things, tends to be cyclical. Antibody-based therapy is once again attracting scientists and clinicians. There are several reasons for the renewed optimism; certainly the expe- ence of the last two decades has provided a wealth of information about problems associated with antibody therapy, and possible solutions to these problems. Recombinant antibody engineering has rejuvenated the field, allowing both the modification of antibodies to improve their in vivo pr- erties and the isolation of novel antibody molecules by such techniques as phage display. The results of recent clinical trials have demonstrated unequivocally the benefit of antibody t
出版日期Book 2000
版次1
doihttps://doi.org/10.1385/1592590764
isbn_softcover978-1-61737-195-0
isbn_ebook978-1-59259-076-6Series ISSN 1543-1894 Series E-ISSN 1940-6037
issn_series 1543-1894
copyrightHumana Press 2000
The information of publication is updating

書目名稱Diagnostic and Therapeutic Antibodies影響因子(影響力)




書目名稱Diagnostic and Therapeutic Antibodies影響因子(影響力)學科排名




書目名稱Diagnostic and Therapeutic Antibodies網(wǎng)絡公開度




書目名稱Diagnostic and Therapeutic Antibodies網(wǎng)絡公開度學科排名




書目名稱Diagnostic and Therapeutic Antibodies被引頻次




書目名稱Diagnostic and Therapeutic Antibodies被引頻次學科排名




書目名稱Diagnostic and Therapeutic Antibodies年度引用




書目名稱Diagnostic and Therapeutic Antibodies年度引用學科排名




書目名稱Diagnostic and Therapeutic Antibodies讀者反饋




書目名稱Diagnostic and Therapeutic Antibodies讀者反饋學科排名




單選投票, 共有 1 人參與投票
 

0票 0.00%

Perfect with Aesthetics

 

0票 0.00%

Better Implies Difficulty

 

0票 0.00%

Good and Satisfactory

 

1票 100.00%

Adverse Performance

 

0票 0.00%

Disdainful Garbage

您所在的用戶組沒有投票權(quán)限
沙發(fā)
發(fā)表于 2025-3-21 20:17:49 | 只看該作者
Polyclonal and Monoclonal Antibodies unlimited supply of a single antibody that is clearly defined and of reproducible specificity and affinity is of greater value. To produce such a reagent it is necessary to isolate and culture a single clone of B lymphocytes secreting antibody of the appropriate characteristics-that is, to produce
板凳
發(fā)表于 2025-3-22 00:46:28 | 只看該作者
地板
發(fā)表于 2025-3-22 05:44:22 | 只看該作者
5#
發(fā)表于 2025-3-22 09:42:43 | 只看該作者
Antibody-Based Therapies in Infectious Diseasesccesses with immune serum were observed in treatment and prevention of other infectious diseases, which include . meningitis, measles, diphtheria, hepatitis A and B, poliovirus infection, and cytomegalovirus (CMV) infection (.). However, numerous problems have been observed with immune sera, includi
6#
發(fā)表于 2025-3-22 13:17:13 | 只看該作者
Antibodies for Immunoassayshormones, peptides, e.g., vasopressin, proteins, e.g., cytokines, as well as carbohydrate structures, e.g., CA-125. Immunoassay technology has developed to such an extent that it is probably the most versatile analytical tool available able to identify and quantify epitopic structures across the mil
7#
發(fā)表于 2025-3-22 20:01:10 | 只看該作者
8#
發(fā)表于 2025-3-23 01:03:30 | 只看該作者
9#
發(fā)表于 2025-3-23 05:28:04 | 只看該作者
10#
發(fā)表于 2025-3-23 06:35:38 | 只看該作者
B. Müller,A. Marek,H.-Th. Jankapersonal communication) have recently achieved more than 70% complete responses in posttransplant lymphoma treated with a chimeric anti-CD20 mAb, and Maloney and co-workers (.) recently reported a 50% response rate in relapsed, low-grade, NHL, with a 10---11 mo duration. Encouragingly, patients in t
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學 Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點評 投稿經(jīng)驗總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學 Yale Uni. Stanford Uni.
QQ|Archiver|手機版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-10 19:23
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復 返回頂部 返回列表
博乐市| 汪清县| 霸州市| 芜湖市| 政和县| 乌鲁木齐市| 扎鲁特旗| 庄河市| 鄄城县| 霍州市| 临颍县| 扎兰屯市| 固阳县| 磐安县| 启东市| 常山县| 温州市| 台州市| 舒兰市| 吉木乃县| 台中市| 普定县| 巫溪县| 吉水县| 阿尔山市| 达拉特旗| 澄城县| 临清市| 耿马| 开江县| 高安市| 长白| 扶沟县| 和林格尔县| 嘉善县| 贡嘎县| 上高县| 开封县| 镇远县| 玉屏| 敦化市|